Brief: Pasithea Therapeutics Acquires Alpha-5 Integrin LLC
22/06/2022 14:23
June 22 (Reuters) - Pasithea Therapeutics Corp KTTA.O :
* PASITHEA THERAPEUTICS ACQUIRES ALPHA-5 INTEGRIN, LLC
* PASITHEA THERAPEUTICS CORP - CLOSING CONSIDERATION OF 3.26
MILLION SHARES OF PASITHEA COMMON STOCK
* PASITHEA THERAPEUTICS CORP - ACQUIRED ALL OF OUTSTANDING
EQUITY
INTERESTS IN ALPHA-5 AT AN ENTERPRISE VALUE FOR $3.75 MILLION
Source text for Eikon: ID:nGNX2dbBk4
Further company coverage: KTTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pasithea Therapeutics
See all newsPasithea Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary
Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data
Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock
Pasithea Therapeutics jumps after $60 million public offering announcement